While immunotherapies have transformed treatment of many types of cancer, they do sometimes fail to have an impact – as Merck & Co has just observed in a study of Keytruda in head and neck cancer.

These blow-up pillows support your head and neck so you can get ... in that it doesn’t loop around the neck but acts as a headrest. Its small size makes it both wonderfully portable and ...

Adding perioperative pembrolizumab to standard care can improve EFS in locally advanced head and neck cancer, data suggest.

Definitive radiotherapy is the standard treatment for head and neck squamous cell carcinoma, but it often leads to significant long-term side effects, particularly from elective neck irradiation.

Low-dose computed tomography is more sensitive than chest radiography in detecting lung metastases or second primary lung cancer in patients with HNSCC.

Reducing the dose of radiation to nodal regions is safe and does not impact the risk of recurrence in patients with head and neck cancer, a study suggests.

Citation: Adding perioperative pembrolizumab improves outcomes in patients with newly diagnosed head and neck cancer: Trial (2025, April 29) retrieved 4 May 2025 from https://medicalxpress.com ...

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

Lymphedema, a chronic condition marked by fluid buildup and tissue swelling, comes in two types—primary and secondary—each ...

The FDA has started a priority review of MSD's Keytruda as neoadjuvant and adjuvant treatment of locally advanced head and neck squamous cell carcinoma (HNSCC), with a decision due by 23rd June.